Clinical Trials Sponsored by Metagenics, Inc.

Total 35326 results

Metagenics, Inc.

Completed

Oral Nutritional Supplement Effect on HDL Function

HDL

United States
Metagenics, Inc.

Completed

ERr 731® Formulation Evaluation (EFE1)

Menopause

United States
Metagenics, Inc.
MetaProteomics LLC

Completed

LIFEHOUSE: Description of the Tent Bucket -Immune Support (LIFEHOUSE)

Immune Response

United States
Metagenics, Inc.
MetaProteomics LLC

Completed

Personal Lifestyle Engine (PLX) - Personal Lifestyle Medicine Center (PLMC)

Autoimmune Diseases | Health, Subjective | Gastrointestinal Dysfunction | Cardiovascular Risk Factor | Neurocognitive Dysfunction | Dental Diseases | Hormone Disturbance

United States
Metagenics Europe

Terminated

Evaluation of a Nutraceutical for Endometriosis Pain Relief

Endometriosis

Belgium
Joslin Diabetes Center
Metagenics, Inc.

Completed

The Effect of 3 Different Models of MNT on DM Control in Overweight Patients With T2DM

Obesity | Type 2 Diabetes

United States
Metagenics, Inc.
Hypertension Institute, Nashville

Active, not recruiting

HDL Function Dietary Supplement Safety and QOL

Health, Subjective | HDL

United States
Metagenics, Inc.
Tufts Medical Center; MetaProteomics LLC

Completed

Personalized Lifestyle Intervention for Improving Functional Health Outcomes Using N-of-1 Tent-Umbrella-Bucket Design (LIFE-HOUSE)

Autoimmune Diseases | Health, Subjective | Gastrointestinal Dysfunction | Cardiovascular Risk Factor | Neurocognitive Dysfunction | Dental Diseases | Hormone Disturbance

United States
Metagenics, Inc.
National University of Natural Medicine

Completed

Effect of UGIR in Adults With Compromised Gut Function and Malabsorption

Irritable Bowel Syndrome | Celiac Disease | Crohn Disease | Ulcerative Colitis
Metagenics, Inc.
National University of Natural Medicine

Completed

Prospective Tolerability Assessment of a Probiotic Dietary Supplement

Healthy Adults

United States
Queen Mary University of London
Metagenics, Inc.

Unknown

SPM Regulation by Fish Oil Supplements in Healthy Volunteers

Healthy Volunteers

United Kingdom
GrowBaby Life Project
Metagenics, Inc.; OmegaQuant, LLC

Not yet recruiting

Select Nutrient and Gene Variant Analysis in a Targeted Diet and Lifestyle Intervention Reduces Preterm Birth (SNGLI-PTB)

Premature Birth | Pre-Eclampsia | Small for Gestational Age Infant

United States
National University of Natural Medicine
Metagenics, Inc.

Completed

Influence of an Omega-3 SPM Supplement on Quality of Life

Chronic Pain

United States
National University of Natural Medicine
Metagenics, Inc.; Dr. Kara Fitzgerald, ND

Active, not recruiting

Methylation Diet and Lifestyle Study (MDL)

Healthy | Diet | Lifestyle

United States
Metagenics, Inc.
National University of Natural Medicine; Personalized Lifestyle Medicine Center

Completed

Resistant Starch Blend Gastrointestinal Impact

Quality of Life | Health, Subjective

United States
Medgenics Medical Israel Ltd.

Terminated

Safety and Biological Activity of InfraDure Biopump Secreting Sustained Interferon in HCV Patients

Hepatitis C
Medgenics Medical Israel Ltd.

Completed

Safety and Efficacy of Sustained Erythropoietin Therapy

Anemia

Israel
Medgenics Medical Israel Ltd.

Terminated

Epodure Therapy of Anemia in End Stage Renal Disease on Dialysis With Epodure Skin Implant

Anemia | End Stage Renal Disease
Medgenics Medical Israel Ltd.

Withdrawn

Safety and Efficacy of Sustained Interferon Alfa 2b (INF) Therapy of Relapsing Hepatitis C (HCV) Patients Using InfraDure Biopump

Hepatitis C

Israel
University of North Carolina, Chapel Hill
Metagenics, Inc.; North Carolina Translational and Clinical Sciences Institute

Completed

Bioavailability of SPMs in Obese Humans

Obesity Adult Onset

United States
Aevi Genomic Medicine, LLC, a Cerecor company
Medgenics Medical Israel Ltd.

Terminated

TARGTEPO Treatment for Anemia in PD US Trial

Anemia of End Stage Renal Disease

United States
Aevi Genomic Medicine, LLC, a Cerecor company
Medgenics Medical Israel Ltd.

Terminated

TARGTEPO Treatment for Anemia in End Stage Renal Disease (ESRD) Patients Undergoing Peritoneal Dialysis (PD)

Anemia of End Stage Renal Disease

Israel
Aevi Genomic Medicine, LLC, a Cerecor company
Medgenics Medical Israel Ltd.

Completed

TARGTEPO Treatment for Anemia in Chronic Kidney Disease (CKD) Patients and End-Stage Renal Disease (ESRD)

End Stage Renal Disease | Chronic Kidney Disease

Israel
IND Diagnostic Inc.

Unknown

Evaluation of the IND One Step Strep A Rapid Test vs. Culture

Strep Throat

United States
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.; Oncoceutics, Inc.

Recruiting

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

Metastasis | Endometrial Cancer

United States
NC Medial Research Inc

Recruiting

A Study of NCS-01 in Patients With Acute Ischemic Stroke

Ischemic Stroke

United States
IC-IT Sciences Inc.

Unknown

Comparison of the Natural Frequencies Technology Sleep Patches to Sham Patches During Sleep in the Home Environment

Sleep Disturbance

United States
Zhengzhou Gensciences Inc
Haimen Gensciences lnc

Completed

An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A.

Hemophilia A

China
Zhengzhou Gensciences Inc
Jiangsu Gensciences lnc.

Completed

Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A (RH-107-III02)

Hemophilia A

China
UNC Lineberger Comprehensive Cancer Center
Seagen Inc.

Completed

Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma

Hodgkin Lymphoma, Adult

United States
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Terminated

Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids (NRR)

Graft Versus Host Disease

United States
UNC Lineberger Comprehensive Cancer Center
Veracyte, Inc.

Recruiting

Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA (HARMONY)

Breast Cancer

United States
UNC Lineberger Comprehensive Cancer Center
Seagen Inc.

Active, not recruiting

BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma

Lymphoma | Lymphatic Diseases | Adult T-Cell Leukemia/Lymphoma

United States
IGC Pharma LLC

Completed

Study of IGC-AD1 in Subjects With Dementia Due to Alzheimer's Disease

Dementia of Alzheimer Type

Puerto Rico
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Completed

Cancer Patients' Performance Status Assessed Using Cardiopulmonary Exercise Testing and Wearable Data Generation

Hematologic Malignancies | Malignant Solid Tumor

United States
IGC Pharma LLC

Recruiting

IGC-AD1 Trial on Agitation in Dementia Due to Alzheimer's (IGC-AD1-P2)

Aggression | Depression | Anxiety | Alzheimer Disease | Memory Impairment | Agitated; State, Acute Reaction to Stress | Agitation,Psychomotor | Care Giving Burden | NPS | Aggressive Outburst

United States, Canada, Puerto Rico
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Recruiting

Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma

Diffuse Large B-cell Lymphoma

United States
Novan, Inc.
Synteract, Inc.; Therapeutics, Inc.

Completed

A Phase 3 Molluscum Contagiosum Efficacy and Safety Study (B-SIMPLE4)

Molluscum Contagiosum

United States
OBELAB, Inc.
Helptrial Inc.

Not yet recruiting

Evaluation of rSO2 Between Frontal Lesion Area and Normal Area of Brain by NIRSITX Using NIRS in Acute Ischemic Stroke Patients.

Acute Ischemic Stroke Patients

Korea, Republic of
Athersys, Inc
Medpace, Inc.

Recruiting

MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study (MASTERS-2)

Ischemic Stroke

United States, Taiwan
89bio, Inc.
ProSciento, Inc.

Completed

A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH

NASH

United States, Puerto Rico
ModernaTX, Inc.
Aetion, Inc.

Active, not recruiting

Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran

SARS-CoV-2

United States
Eisai Inc.
Quintiles, Inc.

Terminated

FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer

Colorectal Cancer

United States, Australia, Russian Federation, India, Ukraine
AxeroVision, Inc.
ORA, Inc.

Completed

A Study to Evaluate AXR-159 Ophthalmic Solution in Patients With Dry Eye Disease

Dry Eye

United States
Versartis Inc.

Completed

Long-Acting Growth Hormone in Children Compared to Daily rhGH (VELOCITY)

Growth Disorders
Novan, Inc.
Synteract, Inc.

Completed

A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE1)

Molluscum Contagiosum

United States
EmitBio Inc.

Completed

Phase I/II Safety, Dose Finding & Antiviral Activity of RD-X19 in Mild/Moderate Outpatient COVID-19

COVID19

United States
Xoft, Inc.
Icad, Inc.

Withdrawn

An Efficacy Study of the Xoft® Axxent® eBx® IORT System® "Lite"

Ductal Carcinoma In Situ | Invasive Ductal Carcinoma
Versartis Inc.

Completed

Versartis Trial in Children to Assess Long-Acting Growth Hormone (VERTICAL)

Pediatric Growth Hormone Deficiency

United States
EmitBio Inc.

Completed

Evaluation of the RD-X19 Treatment Device in Individuals With Mild to Moderate COVID-19

COVID19

United States

Clinical Trials Sponsored by Metagenics, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations